WO2004059000A3 - Procede de criblage adapte a un haut debit pour l'identification de principes actifs - Google Patents

Procede de criblage adapte a un haut debit pour l'identification de principes actifs Download PDF

Info

Publication number
WO2004059000A3
WO2004059000A3 PCT/EP2003/013564 EP0313564W WO2004059000A3 WO 2004059000 A3 WO2004059000 A3 WO 2004059000A3 EP 0313564 W EP0313564 W EP 0313564W WO 2004059000 A3 WO2004059000 A3 WO 2004059000A3
Authority
WO
WIPO (PCT)
Prior art keywords
active substances
screening method
cultivation
throughput screening
identifying active
Prior art date
Application number
PCT/EP2003/013564
Other languages
German (de)
English (en)
Other versions
WO2004059000A2 (fr
Inventor
Dietmar Eschrich
Juergen Recktenwald
Karl-Dieter Entian
Original Assignee
Phenion Gmbh & Co Kg
Dietmar Eschrich
Juergen Recktenwald
Karl-Dieter Entian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenion Gmbh & Co Kg, Dietmar Eschrich, Juergen Recktenwald, Karl-Dieter Entian filed Critical Phenion Gmbh & Co Kg
Priority to AU2003298160A priority Critical patent/AU2003298160A1/en
Publication of WO2004059000A2 publication Critical patent/WO2004059000A2/fr
Publication of WO2004059000A3 publication Critical patent/WO2004059000A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un procédé de criblage adapté à un haut débit pour l'identification de principes actifs.
PCT/EP2003/013564 2002-12-20 2003-12-02 Procede de criblage adapte a un haut debit pour l'identification de principes actifs WO2004059000A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003298160A AU2003298160A1 (en) 2002-12-20 2003-12-02 High-throughput screening method for identifying active substances by means of co-cultivation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2002161834 DE10261834A1 (de) 2002-12-20 2002-12-20 Hochdurchsatz-geeignetes Screening-Verfahren zur Identifikation von Wirkstoffen
DE10261834.8 2002-12-20

Publications (2)

Publication Number Publication Date
WO2004059000A2 WO2004059000A2 (fr) 2004-07-15
WO2004059000A3 true WO2004059000A3 (fr) 2004-09-30

Family

ID=32478134

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/013564 WO2004059000A2 (fr) 2002-12-20 2003-12-02 Procede de criblage adapte a un haut debit pour l'identification de principes actifs

Country Status (3)

Country Link
AU (1) AU2003298160A1 (fr)
DE (1) DE10261834A1 (fr)
WO (1) WO2004059000A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008521427A (ja) * 2004-12-01 2008-06-26 エフ２ジー リミテッド 菌類のシグナル伝達および代謝酵素
WO2007047800A2 (fr) 2005-10-20 2007-04-26 Transocean Sedco Forex Ventures Ltd. Dispositif et procede pour forage sous pression controlee
US11060979B2 (en) 2014-12-19 2021-07-13 General Electric Company System and method for engine inspection

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006132A2 (fr) * 1993-08-27 1995-03-02 Myco Pharmaceuticals, Incorporated Identification d'agents biologiquement actifs par changement de couleur
WO1998021355A1 (fr) * 1996-11-15 1998-05-22 Life Technologies, Inc. Mutants de la proteine fluorescente verte
WO2001040518A1 (fr) * 1999-12-03 2001-06-07 Rosetta Inpharmatics, Inc. Procedes cibles de criblage de drogues fondes sur la co-culture
US6303115B1 (en) * 1996-06-17 2001-10-16 Microcide Pharmaceuticals, Inc. Screening methods using microbial strain pools

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150137A (en) * 1994-05-27 2000-11-21 Ariad Pharmaceuticals, Inc. Immunosuppressant target proteins
US20030104362A1 (en) * 1995-06-05 2003-06-05 Guillaume Cottarel Cell-cycle regulatory proteins from human pathogens, and uses related thereto

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006132A2 (fr) * 1993-08-27 1995-03-02 Myco Pharmaceuticals, Incorporated Identification d'agents biologiquement actifs par changement de couleur
US6303115B1 (en) * 1996-06-17 2001-10-16 Microcide Pharmaceuticals, Inc. Screening methods using microbial strain pools
WO1998021355A1 (fr) * 1996-11-15 1998-05-22 Life Technologies, Inc. Mutants de la proteine fluorescente verte
WO2001040518A1 (fr) * 1999-12-03 2001-06-07 Rosetta Inpharmatics, Inc. Procedes cibles de criblage de drogues fondes sur la co-culture

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GIAEVER G ET AL: "GENOMIC PROFILING OF DRUG SENSITIVITIES VIA INDUCED HAPLOINSUFFICIENCY", NATURE GENETICS, NATURE AMERICA, NEW YORK, US, vol. 21, no. 3, March 1999 (1999-03-01), pages 278 - 283, XP001025981, ISSN: 1061-4036 *

Also Published As

Publication number Publication date
AU2003298160A1 (en) 2004-07-22
WO2004059000A2 (fr) 2004-07-15
AU2003298160A8 (en) 2004-07-22
DE10261834A1 (de) 2004-07-08

Similar Documents

Publication Publication Date Title
WO2004048514A3 (fr) Methodes d'analyse d'un acide nucleique
CA2545989A1 (fr) Procede et dispositif de purification d'acides nucleiques
AU2003267514A1 (en) Method for making nitrile compounds from ethylenically unsaturated compounds
AU2002350039A1 (en) Method for isolating cell-type specific mrnas
AU2002334321A1 (en) Method for the production of phytoalexins
AU2002952747A0 (en) Method for analysing peptides
AU2003283174A1 (en) Method for protein production
AU2003293895A1 (en) Method for the production of isocyanates
AU2003216403A1 (en) Method for the recombination of genetic elements
AU2003277663A1 (en) Screening method
AU2003214055A1 (en) Method for screening for compounds having hdac inhibitory activity
AU2003263756A1 (en) Methods for peptide-protein binding prediction
AU2003293477A1 (en) Method for the production of polycarbonates
AU2003236804A1 (en) Method for the biotechnological production of xylitol
WO2004059000A3 (fr) Procede de criblage adapte a un haut debit pour l'identification de principes actifs
AU2003242340A1 (en) Novel screening method
AU2003261957A1 (en) Method for separating substances
AU2003269047A1 (en) Method for making biochips
WO2004011449A3 (fr) Procede de production de derives de phenylalanine
AU2003234171A1 (en) Method for evaluating drug candidates
AU2003243889A1 (en) Method for the production of osb plates
AU2003258622A1 (en) Method for the production of $g(b)-carotinoids
AU2003277030A1 (en) Method for screening molecular interactions
AU2002352042A1 (en) Method for the detection of prpsc
AU2003227268A1 (en) Novel screening method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR BY CA CN DZ ID IL IN JP KR MX NO NZ PL RU SG UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP